CONMED Corporation CNMD
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.37B | 1.37B | 1.37B | 1.37B | 1.35B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.37B | 1.37B | 1.37B | 1.37B | 1.35B |
| Cost of Revenue | 612.15M | 609.35M | 624.24M | 630.75M | 595.24M |
| Gross Profit | 757.14M | 762.31M | 746.27M | 743.98M | 752.24M |
| SG&A Expenses | 539.17M | 539.96M | 536.71M | 548.12M | 545.15M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.21B | 1.21B | 1.22B | 1.23B | 1.19B |
| Operating Income | 155.65M | 161.72M | 150.29M | 139.97M | 152.92M |
| Income Before Tax | 104.96M | 83.23M | 81.80M | 71.12M | 85.51M |
| Income Tax Expenses | 31.53M | 26.73M | 26.95M | 24.06M | 21.44M |
| Earnings from Continuing Operations | 73.43 | 56.50 | 54.85 | 47.06 | 64.07 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 73.43M | 56.50M | 54.85M | 47.06M | 64.07M |
| EBIT | 155.65M | 161.72M | 150.29M | 139.97M | 152.92M |
| EBITDA | 230.37M | 235.86M | 223.96M | 213.05M | 224.96M |
| EPS Basic | 2.42 | 1.85 | 1.78 | 1.52 | 2.07 |
| Normalized Basic EPS | 2.56 | 2.74 | 2.42 | 2.18 | 2.42 |
| EPS Diluted | 2.42 | 1.85 | 1.77 | 1.51 | 2.05 |
| Normalized Diluted EPS | 2.56 | 2.74 | 2.42 | 2.18 | 2.41 |
| Average Basic Shares Outstanding | 121.55M | 122.58M | 123.46M | 123.85M | 123.80M |
| Average Diluted Shares Outstanding | 121.89M | 122.82M | 123.76M | 124.29M | 124.40M |
| Dividend Per Share | 0.00 | 0.20 | 0.40 | 0.60 | 0.80 |
| Payout Ratio | 8.43% | 21.91% | 33.85% | 52.59% | 38.60% |